<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="555.324 deaths in the world (July 10, 2020). No vaccine" exact="treatment" post="has been defined against SARS-CoV2 or other human coronaviruses"/>
 <result pre="interventions against viral diseases need a comprehensive view on the" exact="infection" post="dynamics and on necessary treatments. Viral targeting compounds to"/>
 <result pre="in anti-HCoV, a web accessible resource to be exploited for" exact="testing" post="and in vivo trials. The website is here launched"/>
 <result pre="â€¢HCoVs similarities suggest possible similar action against them. â€¢No official" exact="treatment" post="for prevention and care against HCoVs is yet approved."/>
 <result pre="effective preventive vaccine or efficient antiviral therapies to treat coronavirus" exact="infection" post="diseases and to limit the main cause of death"/>
 <result pre="or relief the effects of the human response to the" exact="infection" post="is of fundamental importance for fighting COVID19 and similar"/>
 <result pre="of interest since they also determine the efficiency of the" exact="infection" post="and its spreading (Zhou et al., 2020). Spike proteins"/>
 <result pre="compounds had high antiviral activity from 3Â h before the" exact="infection" post="with HCoV-OC43. On the other hand, the treatments at"/>
 <result pre="MERS-CoV) (Raj et al., 2013) in mouse and tested mouse" exact="infection" post="by MERS-CoV. They treated infected mouse with resveratrol and"/>
 <result pre="tested, the authors suggested the baicalin for both prophylaxis or" exact="treatment" post="SARS-CoV infectious disease. The intravenous administration of a 360Â"/>
 <result pre="known, regarding HIV-1 infections, baicalin was shown to inhibit the" exact="infection" post="process both at cellular entry and through the inhibition"/>
 <result pre="be inhibited by lectins, that specifically bind to glycans. The" exact="screening" post="of many plant lectins tested on Vero E6 cells"/>
 <result pre="YBS40) than on human N7-MTase (yeast-based assays for the high-throughput" exact="screening" post="of inhibitors of coronavirus RNA cap guanine-N7-methyltransferase) indicating its"/>
 <result pre="cells. The decreased antiviral activity was then evaluated with an" exact="immunofluorescence" post="assay to identify the presence of antibodies against viral"/>
 <result pre="the virus. After the addition of active compounds, the viral" exact="infection" post="and replication was sharply reduced resulting in and increased"/>
 <result pre="by Chen et al. (2006) The authors, though a virtual" exact="screening" post="based firstly on molecular docking, found quercetin-3-Î²-galactoside to be"/>
 <result pre="for Human Use (ICH) that indicated the guidelines for toxicity" exact="testing" post="of pharmaceutical compounds to ensuring human drug safety (Guideline"/>
 <result pre="development, evaluation, and implementation of in vitro alternatives to animal" exact="testing" post="in the hazard identification and risk assessment of preclinical"/>
 <result pre="et al., 2015). The safety assessment of drugs requires first" exact="testing" post="in toxicology species prior to human studies (Guideline &amp;amp;"/>
 <result pre="identified in toxicology species (Olson et al., 2000). Although the" exact="detection" post="of toxicity is dependent by organ and species, its"/>
 <result pre="In fact, multiple drug therapies are very common for the" exact="treatment" post="of various medical illnesses thus being a potential source"/>
 <result pre="the aescin have been selected to undergo clinical trials for" exact="testing" post="their efficacy in patients affected by human coronaviruses. In"/>
 <result pre="group with a poor or no response to standard medical" exact="treatment" post="and without invasive mechanical ventilation are planned to receive"/>
 <result pre="mg once a day), in tablets form, with the standard" exact="treatment" post="of mild and severe neo-coronary pneumonia. The aim is"/>
 <result pre="this collection with additional information on future results from novel" exact="testing" post="and trials, enriching the dataset with more upcoming compounds,"/>
 <result pre="Foods Health Dis5201010.31989/ffhd.v1i5.132 BalunasM.J.KinghornA.D.Drug discovery from medicinal plantsLife Sciences785200543144110.1016/j.lfs.2005.09.01216198377 BergmannC.LaneT.StohlmanS.Coronavirus" exact="infection" post="of the central nervous system: Host-virus stand-offNature Reviews Microbiology4200612113210.1038/nrmicro134316415928"/>
 <result pre="Letters9520152381238710.3892/ol.2015.298826137075 GohJ.-Y.WeaverR.J.DixonL.PlattN.J.RobertsR.A.Development and use of in vitro alternatives to animal" exact="testing" post="by the pharmaceutical industry 1980â€&quot;2013Toxicology Research4520151297130710.1039/c5tx00123d GonzÃ¡lezM.A.Aromatic abietane diterpenoids:"/>
 <result pre="trials and marketing authorization for pharmaceuticals2009ICH, European Medicines Agency HarveyA.L.CreeI.A.High-throughput" exact="screening" post="of natural products for cancer therapyPlanta Medica761120101080108610.1055/s-0030-125016220635309 HoffmannM.Kleine-WeberH.SchroederS.KrÃ¼gerN.HerrlerT.ErichsenS. â€¦PÃ¶hlmannS.SARS-CoV-2"/>
 <result pre="KimD.E.MinJ.S.JangM.S.LeeJ.Y.ShinY.S.SongJ.H.KimH.R.KimS.JinY.-H.KwonS.Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43" exact="infection" post="of MRC-5 human lung cellsBiomolecules911201910.3390/biom9110696 KorkinaL.KostyukV.De LucaC.PastoreS.Plant phenylpropanoids as"/>
 <result pre="antiviral activities against SARS-associated coronavirusAntiviral Research6712005182310.1016/j.antiviral.2005.02.00715885816 LinS.-C.HoC.-T.ChuoW.-H.LiS.WangT.T.LinC.-C.Effective inhibition of MERS-CoV" exact="infection" post="by resveratrolBMC Infectious Diseases171201714410.1186/s12879-017-2253-828193191 LinL.-T.HsuW.-C.LinC.-C.Antiviral natural products and herbal"/>
 <result pre="of Infectious Diseases165201246647110.1016/j.bjid.2012.08.014 PyrcK.BoschB.J.BerkhoutB.JebbinkM.F.DijkmanR.RottierP.van der HoekL.Inhibition of human coronavirus NL63" exact="infection" post="at early stages of the replication cycleAntimicrobial Agents and"/>
 <result pre="statinsJournal of Fungi (Basel, Switzerland)22201610.3390/jof2020013 SunY.WangZ.TaoJ.WangY.WuA.YangZ.WangK.ShiL.ChenY.GuoD.Yeast-based assays for the high-throughput" exact="screening" post="of inhibitors of coronavirus RNA cap guanine-N7-methyltransferaseAntiviral Research104201415616410.1016/j.antiviral.2014.02.00224530452 TorresM.C.M.Braz-FilhoR.SilveiraE.R.DinizJ.C.VianaF.A.PessoaO.D.L.Terpenoids"/>
 <result pre="targeting HR1 domain in spike proteinCellular and Molecular Immunology177202076576710.1038/s41423-020-0374-232047258 XuH.-B.MaY.-B.HuangX.-Y.GengC.-A.WangH.ZhaoY.YangT.-H.ChenX.-L.YangC.-Y.ZhangX.-M.ChenJ.-J.Bioactivity-guided" exact="isolation" post="of anti-hepatitis B virus active sesquiterpenoids from the traditional"/>
 <result pre="a basis for design of improved Î±-ketoamide inhibitorsScience3686489202040941210.1126/science.abb340532198291 ZhangD.-H.WuK.-L.ZhangX.DengS.-Q.PengB.In silico" exact="screening" post="of Chinese herbal medicines with the potential to directly"/>
</results>
